Deb Balzer (@DebBalzer)
Deb Balzer is a Senior Communications Specialist at Mayo Clinic. She began her career as a TV news producer in Rochester, NY, before joining CONUS Communications, a pioneering national news satellite organization. She also field produced for ABC, CNN, the Rachael Ray Show and Farmers’ Almanac TV. Joining Mayo Clinic in 2015, Deb writes, produces and collaborates on medical stories with Mayo Clinic’s leading experts, providing trusted health and medical information to help patients.
The infection rate of omicron, the highly infectious variant of COVID-19, is doubling about every two days, says Dr. Gregory Poland, an infectious diseases expert and[...]
There are times when the hustle and bustle in the Nathan Landow Atrium of the Gonda Building at Mayo Clinic in Rochester, Minnesota, comes to[...]
Like checking the weather before making traveling plans, members of the Mayo Clinic Predictive Modeling Task Force are hoping people turn to the U.S. COVID-19[...]
It’s been one year since hope arrived at Mayo Clinic in form of a vaccine to help slow the spread of COVID-19 infection. Since December[...]
This past week, the Food and Drug Administration (FDA) and Centers for Disease Control and Prevention (CDC) authorized Pfizer COVID-19 booster vaccinations for 16 and[...]
The COVID-19 omicron variant has been reported in nearly half of the U.S. states since it was first detected in California on Dec. 1. The[...]
The Centers for Disease Control and Prevention and Mayo Clinic recommend delaying travel until you and your family are fully vaccinated against COVID-19. If you[...]
Vaccine drugmaker Pfizer says its studies show three doses of its COVID-19 vaccine neutralized the omicron variant while two doses reduced severity. "These are studies[...]
On Monday, December 6, 2021 Mayo Clinic’s leading experts on COVID-19 treatments and therapeutics. Dr. Andrew Badley and Dr. Raymund Razonable discussed the new antiviral pills for the treatment of COVID,[...]
The emergence of a new COVID-19 variant, omicron, has heightened safety protocols and plans to help people stay safe from illness as researchers and experts[...]
On Thursday, December 2, Matthew Binnicker, Ph.D., Vice-Chair of Practice, Department of Laboratory Medicine and Pathology at Mayo Clinic addressed testing for the COVID-19 omicron variant[...]
The first oral antiviral medication to treat COVID-19 is one step closer. A Food and Drug Administration (FDA) advisory panel has voted to recommend emergency[...]